Palmitoylcarnitine chloride, a fatty acid-derived mitochondrial substrate, selectively decreases colorectal and prostate cancer cell survival by affecting pro-inflammatory pathways, Ca2+ influx, and DHT-like effects.
| Purity | 0.98 |
|---|---|
| Formula | C23H46ClNO4 |
| Molecular Weight | 436.07 |
| SMILES | CCCCCCCCCCCCCCCC(OC(CC(O)=O)C[N+](C)(C)C)=O.[Cl-] |
| Appearance | Solid |
| Color | White to off-white |
| Biological Target | Endogenous Metabolite; Akt; Calcium Channel |
| Initial Source | Endogenous metabolite |
| Solubility | H2O: 50 mg/mL (114.66 mM, need ultrasonic); DMSO: 8.33 mg/mL (19.10 mM, ultrasonic and warming and heat to 60°C) |
| Shipping Conditions | Room Temperature |
| Storage Information | -20°C, sealed storage, away from moisture |
Datasheet